Intrathecal hydrocortisone for treatment of children and young adults with CAR T‐cell immune‐effector cell‐associated neurotoxicity syndrome
出版年份 2023 全文链接
标题
Intrathecal hydrocortisone for treatment of children and young adults with CAR T‐cell immune‐effector cell‐associated neurotoxicity syndrome
作者
关键词
-
出版物
PEDIATRIC BLOOD & CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-28
DOI
10.1002/pbc.30741
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- How I treat unique and difficult to manage cases of CAR T-cell therapy associated neurotoxicity
- (2023) Bianca D Santomasso et al. BLOOD
- Tumor inflammation-associated neurotoxicity
- (2023) Jasia Mahdi et al. NATURE MEDICINE
- Neurotoxicity Following CD19/CD28ζ CAR T-Cells in Children and Young Adults with B-Cell Malignancies
- (2022) Haneen Shalabi et al. NEURO-ONCOLOGY
- CD19/22 CAR T-cells in Children and Young Adults with B-ALL: Phase I Results and Development of a Novel Bicistronic CAR
- (2022) Haneen Shalabi et al. BLOOD
- Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome
- (2022) Joanna C. Zurko et al. JAMA Oncology
- Intrathecal Chemotherapy as a Potential Treatment for Steroid-refractory Immune Effector Cell-associated Neurotoxicity Syndrome
- (2022) PALASH ASAWA et al. ANTICANCER RESEARCH
- Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
- (2021) Bianca D. Santomasso et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
- (2021) P.J. Hayden et al. ANNALS OF ONCOLOGY
- Intrathecal Chemotherapy: An Alternative Treatment Strategy to Prolonged Corticosteroids for Severe CAR T Associated Neurotoxicity
- (2020) Filiz Yucebay et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
- (2020) Nirali N. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome
- (2020) Nirav N. Shah et al. Blood Advances
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
- (2020) Marcela V Maus et al. Journal for ImmunoTherapy of Cancer
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started